"Immunoglobulin G" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
| Descriptor ID |
D007074
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393 D12.776.124.790.651.114.619.393 D12.776.377.715.548.114.619.393
|
| Concept/Terms |
IgG(T)- IgG(T)
- Immunoglobulin GT
- GT, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin G".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin G".
This graph shows the total number of publications written about "Immunoglobulin G" by people in this website by year, and whether "Immunoglobulin G" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 3 | 3 |
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 8 | 8 |
| 1997 | 1 | 10 | 11 |
| 1998 | 2 | 7 | 9 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 8 | 9 |
| 2001 | 5 | 6 | 11 |
| 2002 | 1 | 11 | 12 |
| 2003 | 3 | 7 | 10 |
| 2004 | 3 | 1 | 4 |
| 2005 | 4 | 3 | 7 |
| 2006 | 5 | 3 | 8 |
| 2007 | 5 | 6 | 11 |
| 2008 | 3 | 9 | 12 |
| 2009 | 3 | 5 | 8 |
| 2010 | 3 | 2 | 5 |
| 2011 | 5 | 4 | 9 |
| 2012 | 4 | 7 | 11 |
| 2013 | 4 | 6 | 10 |
| 2014 | 2 | 5 | 7 |
| 2015 | 1 | 9 | 10 |
| 2016 | 3 | 5 | 8 |
| 2017 | 1 | 3 | 4 |
| 2018 | 1 | 6 | 7 |
| 2019 | 4 | 2 | 6 |
| 2020 | 5 | 10 | 15 |
| 2021 | 7 | 12 | 19 |
| 2022 | 0 | 4 | 4 |
| 2023 | 2 | 8 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunoglobulin G" by people in Profiles.
-
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection. Transplantation. 2023 Dec 01; 107(12):2526-2532.
-
Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in Humans. Cancer Res Commun. 2023 11 08; 3(11):2256-2267.
-
A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM). Clin Infect Dis. 2023 10 13; 77(8):1102-1110.
-
Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic? Blood Adv. 2023 08 08; 7(15):4112-4123.
-
IgG4-related sclerosing thyroiditis (Riedel-Struma): a review of clinicopathological features and management. Virchows Arch. 2023 Aug; 483(2):133-144.
-
Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS. Clin Immunol. 2023 05; 250:109324.
-
Immunoglobulin G subclasses confer protection against Staphylococcus aureus bloodstream dissemination through distinct mechanisms in mouse models. Proc Natl Acad Sci U S A. 2023 04 04; 120(14):e2220765120.
-
Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines. Clin Infect Dis. 2023 02 08; 76(3):e439-e449.
-
Treatment options for severe or refractory mpox virus infection in patients with advanced HIV. Int J STD AIDS. 2023 05; 34(6):366-373.
-
No difference in anti-spike antibody and surrogate viral neutralization following SARS-CoV-2 booster vaccination in persons with HIV compared to controls (CO-HIV Study). Front Immunol. 2022; 13:1048776.